title: Prospective strategies to combine conventional, targeted and immunotherapies in non-small cell lung cancer.
abstract: A strategic challenge facing clinicians treating patients afflicted with non-small cell lung cancer (NSCLC) is the development of approaches that combine conventional and novel therapies, including targeted therapies and immunotherapeutics. In a recent study, we explored the correlation between the expression of the tumor antigen family MAGE-A and the presence ofEGFRandKRASgene mutations in a large cohort of resected NSCLC patient specimens.
authors.affiliation: Institut National de la Santé et de la Recherche Médicale; Equipe Labellisée Ligue Contre le Cancer; Institut de Cancérologie de l'Ouest; Nantes, Saint Herblain, France; Faculty of Medicine; University of Nantes; Nantes, France.
authors.forename: Danila
authors.initials: D
authors.lastname: Valmori
authors.affiliation: Institut National de la Santé et de la Recherche Médicale; Equipe Labellisée Ligue Contre le Cancer; Institut de Cancérologie de l'Ouest ; Nantes, Saint Herblain, France.
authors.forename: Maha
authors.initials: M
authors.lastname: Ayyoub
keywords:  MAGE-A; EGFR; KRAS; NSCLC; immune therapy; targeted therapy